drugset / Trial / NCT04934683

The GUARDIAN Trial - Induction Agent Sub-Study

NCT04934683

Phase 4 Enrolling by invitation 6254 enrolled The University of Texas Health Science Center, Houston
RandomizedFactorialDouble-blindPrevention

Summary

This is a sub-study of the overall GUARDIAN trial (NCT04884802) in which some GUARDIAN trial participants will be additionally randomized to etomidate vs propofol for anesthetic induction.

Timeline

Start
2021-07-25
Primary completion
2026-12-31
Completion
2027-04-25

Drugs

EvaluationDrugModalityDoseRoute
Comparator Etomidate Small molecule
Comparator Propofol Small molecule

Indications

No indication recorded.